Schramm Vern Lee 4
4 · AzurRx BioPharma, Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Schramm Vern Lee
Director
Transactions
- Award
Common Stock
2019-06-30$1.70/sh+7,500$12,750→ 52,500 total
Footnotes (1)
- [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2019.